Opus Genetics (NASDAQ:IRD) Earns “Buy” Rating from HC Wainwright
HC Wainwright restated their buy rating on shares of Opus Genetics (NASDAQ:IRD – Free Report) in a research note issued to investors on Tuesday,Benzinga reports. The brokerage currently has a $8.00 target price on the stock. Opus Genetics Stock Performance NASDAQ IRD opened at $0.91 on Tuesday. The firm has a market cap of $29.16 […]
